Hiroyuki Seimiya

19PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 29, 2024
Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal Cancer.

Mitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata

|Apr 26, 2024
Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer.

Jin Lee, Tetsuo Mashima, Naomi Kawata

|Jan 23, 2024
Interleukin-4 induced 1-mediated resistance to an immune checkpoint inhibitor through suppression of CD8+ T cell infiltration in melanoma.

Shiho Hirose, Tetsuo Mashima, Xunmei Yuan

|Nov 25, 2023
YBX1 Regulates Satellite II RNA Loading into Small Extracellular Vesicles and Promotes the Senescent Phenotype.

Masatomo Chiba, Kenichi Miyata, Hikaru Okawa

|Nov 16, 2023
APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells.

Mingjue Chen, Tetsuo Mashima, Taichi Oishi

|Sep 14, 2023
Glutamine deficiency drives transforming growth factor-β signaling activation that gives rise to myofibroblastic carcinoma-associated fibroblasts.

Yoshihiro Mezawa, Tingwei Wang, Yataro Daigo

Pageof 4

Frequent Collaborators

2 joint publications

Tetsuo Mashima

2 joint publications

Kenichi Miyata

2 joint publications

Kengo Takeuchi

2 joint publications

Akiko Takahashi